AnaptysBio Says R&D Spinout May Launch By April

 
• By Joseph Haas
  
bricks
AnaptysBio is fulflling its plan to split into two companies
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business